VENCLEXTA is a BCL-2 inhibitor indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Where can I buy Cometriq?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its presence PAN India with over 20 years of domain experience.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Cometriq (cabozantinib) on prescription and Import License in Patient's Name only.

For Cometriq or cabozantinib price in India. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
Cometriq (cabozantinib)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals Cometriq (cabozantinib) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

20 mg and 80 mg capsules.

ReadMore

Immuno Oncology News

NICE has recommended that two thyroid cancer drugs, Ipsen’s Cometriq (cabozantinib) and Bayer’s Nexavar (sorafenib), should come off the Cancer Drugs Fund and into routine NHS use..
Dated: 19th February 2018

ReadMore